Suppr超能文献

异常蛋白尿作为中国2型糖尿病患者死亡率和肾功能损害的预测指标

Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM.

作者信息

Chan J C, Cheung C K, Cheung M Y, Swaminathan R, Critchley J A, Cockram C S

机构信息

Department of Clinical Pharmacology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories.

出版信息

Diabetes Care. 1995 Jul;18(7):1013-6. doi: 10.2337/diacare.18.7.1013.

Abstract

OBJECTIVE

Microalbuminuria predicts mortality in non-insulin-dependent diabetes mellitus (NIDDM), but its association with deterioration of renal function remains more controversial than in insulin-dependent diabetes mellitus (IDDM). Using albumin-to-creatinine ratios (ACRs) in random spot urine samples is a convenient method for evaluating albuminuria. We studied prospectively the predictive values of albuminuria in NIDDM when assessed by this urine measurement.

RESEARCH DESIGN AND METHODS

Between 1991 and 1992, we restudied the clinical and biochemical status of 403 Chinese NIDDM patients recruited in 1989 after a follow-up period of 26.6 +/- 3.2 months (mean +/- SD). Spot urine ACR was measured on two occasions and microalbuminuria was defined as a mean ACR between 5.6 and 38 mg/mmol.

RESULTS

From the original cohort, 29 patients had died mostly because of cardiovascular events with or without renal failure. The overall relative risk of death in patients with abnormal albuminuria was 7.1 (P < 0.001) (microalbuminuria: 3.7, P = 0.04; macroalbuminuria: 11, P < 0.001). On multivariate analysis, the independent predictive factors for mortality were plasma creatinine (wald = 12.1, P < 0.001) and glucose concentrations (wald = 10.4, P < 0.001) in the normo- and microalbuminuric patients (n = 11) and age (wald = 4.4, P = 0.03) and plasma creatinine (wald = 8.2, P < 0.01) in the macroalbuminuric group (n = 18). In the survivors (n = 374), baseline spot urine ACR was independently associated with 2-year spot urine ACR in the normo- (P < 0.001), micro- (P < 0.01), and macroalbuminuric groups (P = 0.01). In addition, baseline spot urine ACR was independently related to 2-year plasma creatinine (P = 0.01) in the macroalbuminuric group. The rates of change of the reciprocal of plasma creatinine ( delta [Cr]-1) were -27.3 +/- 62.5, -43.4 +/- 68.6, and -108.8 +/- 98.81.mumol01.month-1 in the normo-, micro-, and macroalbuminuric groups, respectively (P < 0.001). The delta [Cr]-1 was independently and inversely related to the baseline spot urine ACR (P < 0.001) and 2-year systolic blood pressure (P < 0.001).

CONCLUSIONS

Abnormal albuminuria as indicated by a random spot urine ACR > 5.6 mg/mmol predicts increased mortality and is associated with the progression of albuminuria and deterioration of renal function in Chinese NIDDM patients.

摘要

目的

微量白蛋白尿可预测非胰岛素依赖型糖尿病(NIDDM)患者的死亡率,但其与肾功能恶化的关联相比胰岛素依赖型糖尿病(IDDM)更具争议性。使用随机尿样中的白蛋白与肌酐比值(ACR)是评估白蛋白尿的便捷方法。我们前瞻性地研究了通过这种尿液检测评估NIDDM患者中白蛋白尿的预测价值。

研究设计与方法

在1991年至1992年期间,我们对1989年招募的403例中国NIDDM患者进行了重新研究,随访期为26.6±3.2个月(均值±标准差)。两次测量随机尿样的ACR,微量白蛋白尿定义为平均ACR在5.6至38mg/mmol之间。

结果

在最初的队列中,29例患者死亡,主要原因是伴有或不伴有肾衰竭的心血管事件。白蛋白尿异常患者的总体死亡相对风险为7.1(P<0.001)(微量白蛋白尿:3.7,P = 0.04;大量白蛋白尿:11,P<0.001)。多因素分析显示,在正常白蛋白尿和微量白蛋白尿患者(n = 11)中,死亡率的独立预测因素是血浆肌酐(wald = 12.1,P<0.001)和血糖浓度(wald = 10.4,P<0.001);在大量白蛋白尿组(n = 18)中,是年龄(wald = 4.4,P = 0.03)和血浆肌酐(wald = 8.2,P<0.01)。在幸存者(n = 374)中,基线随机尿样ACR在正常白蛋白尿组(P<0.001)、微量白蛋白尿组(P<0.01)和大量白蛋白尿组(P = 0.01)中均与2年随机尿样ACR独立相关。此外,在大量白蛋白尿组中,基线随机尿样ACR与2年血浆肌酐独立相关(P = 0.01)。正常白蛋白尿组、微量白蛋白尿组和大量白蛋白尿组血浆肌酐倒数的变化率(δ[Cr]-1)分别为-27.3±62.5、-43.4±68.6和-108.8±98.81μmol-1·月-1(P<0.001)。δ[Cr]-1与基线随机尿样ACR(P<0.001)和2年收缩压(P<0.001)独立且呈负相关。

结论

随机尿样ACR>5.6mg/mmol所提示的异常白蛋白尿可预测中国NIDDM患者死亡率增加,并与白蛋白尿进展及肾功能恶化相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验